Simcere Pharma (02096) has announced a change in its company secretarial roles. Mr. Wan Yushan has stepped down as Joint Company Secretary, effective August 20, 2026, while retaining his positions as Executive Director and Chief Financial Officer.

In a separate announcement, the board confirmed that Mr. Zhu Da, the current Secretary to the Board, has been additionally appointed as Joint Company Secretary, succeeding Mr. Wan in this capacity, with the same effective date of August 20, 2026.

The transition is part of the company's ongoing corporate governance adjustments, ensuring continuity in its secretarial functions.